Title : Does acute promyelocytic leukemia patient with the STAT5B/RARa fusion gene respond well to decitabine?: A case report and literature review.

Pub. Date : 2020 Oct 23

PMID : 33120845






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 LESSONS: APL patients with STAT5B-RARa is not only resistant to ATRA, but also to conventional combination chemotherapy such as daunorubicin and cytarabine/idarubicin and cytarabine or other regimens. Idarubicin retinoic acid receptor alpha Homo sapiens